Orthofix Medical Inc. Common Stock (DE) earnings per share and revenue
On 04 de nov. de 2025, OFIX reported earnings of -0.56 USD per share (EPS) for Q3 25, missing the estimate of -0.41 USD, resulting in a -37.42% surprise. Revenue reached 205.63 milhão, compared to an expected 204.01 milhão, with a 0.80% difference. The market reacted with a -7.41% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.31 USD, with revenue projected to reach 222.94 milhão USD, implying an diminuir of -44.64% EPS, and aumentar of 8.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
What were Orthofix Medical Inc. Common Stock (DE)'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Orthofix Medical Inc. Common Stock (DE) reported EPS of -$0.56, missing estimates by -37.42%, and revenue of $205.63M, 0.8% above expectations.
How did the market react to Orthofix Medical Inc. Common Stock (DE)'s Q3 2025 earnings?
The stock price moved down -7.41%, changed from $16.06 before the earnings release to $14.87 the day after.
When is Orthofix Medical Inc. Common Stock (DE) expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for Orthofix Medical Inc. Common Stock (DE)'s next earnings report?
Based on 5
analistas, Orthofix Medical Inc. Common Stock (DE) is expected to report EPS of -$0.31 and revenue of $222.94M for Q4 2025.